nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP2E1—lung cancer	0.251	0.645	CbGaD
Rufinamide—ALB—lung cancer	0.138	0.355	CbGaD
Rufinamide—CES1—Irinotecan—lung cancer	0.116	0.35	CbGbCtD
Rufinamide—ALB—Gefitinib—lung cancer	0.041	0.123	CbGbCtD
Rufinamide—ALB—Erlotinib—lung cancer	0.0243	0.073	CbGbCtD
Rufinamide—ALB—Irinotecan—lung cancer	0.0219	0.0659	CbGbCtD
Rufinamide—CYP2E1—Etoposide—lung cancer	0.0182	0.0546	CbGbCtD
Rufinamide—CYP3A4—Topotecan—lung cancer	0.0141	0.0423	CbGbCtD
Rufinamide—CYP3A4—Gefitinib—lung cancer	0.0129	0.0387	CbGbCtD
Rufinamide—CYP3A4—Teniposide—lung cancer	0.0125	0.0375	CbGbCtD
Rufinamide—ALB—Methotrexate—lung cancer	0.0116	0.0349	CbGbCtD
Rufinamide—CYP3A4—Vinorelbine—lung cancer	0.00991	0.0298	CbGbCtD
Rufinamide—CYP3A4—Crizotinib—lung cancer	0.00789	0.0237	CbGbCtD
Rufinamide—CYP3A4—Erlotinib—lung cancer	0.00761	0.0229	CbGbCtD
Rufinamide—CYP3A4—Paclitaxel—lung cancer	0.00696	0.0209	CbGbCtD
Rufinamide—CYP3A4—Irinotecan—lung cancer	0.00687	0.0207	CbGbCtD
Rufinamide—CYP3A4—Vinblastine—lung cancer	0.00611	0.0184	CbGbCtD
Rufinamide—CYP3A4—Etoposide—lung cancer	0.0055	0.0165	CbGbCtD
Rufinamide—CYP3A4—Docetaxel—lung cancer	0.00503	0.0151	CbGbCtD
Rufinamide—CYP3A4—Doxorubicin—lung cancer	0.00375	0.0113	CbGbCtD
Rufinamide—Headache—Vinblastine—lung cancer	0.000175	0.00115	CcSEcCtD
Rufinamide—Leukopenia—Etoposide—lung cancer	0.000175	0.00115	CcSEcCtD
Rufinamide—Eye disorder—Docetaxel—lung cancer	0.000175	0.00114	CcSEcCtD
Rufinamide—Insomnia—Irinotecan—lung cancer	0.000174	0.00114	CcSEcCtD
Rufinamide—Cardiac disorder—Docetaxel—lung cancer	0.000173	0.00114	CcSEcCtD
Rufinamide—Infection—Cisplatin—lung cancer	0.000173	0.00113	CcSEcCtD
Rufinamide—Vomiting—Topotecan—lung cancer	0.000173	0.00113	CcSEcCtD
Rufinamide—Vertigo—Paclitaxel—lung cancer	0.000172	0.00113	CcSEcCtD
Rufinamide—Leukopenia—Paclitaxel—lung cancer	0.000172	0.00112	CcSEcCtD
Rufinamide—Rash—Topotecan—lung cancer	0.000172	0.00112	CcSEcCtD
Rufinamide—Hypersensitivity—Vinorelbine—lung cancer	0.000171	0.00112	CcSEcCtD
Rufinamide—Dermatitis—Topotecan—lung cancer	0.000171	0.00112	CcSEcCtD
Rufinamide—Vomiting—Erlotinib—lung cancer	0.000171	0.00112	CcSEcCtD
Rufinamide—Nervous system disorder—Cisplatin—lung cancer	0.000171	0.00112	CcSEcCtD
Rufinamide—Somnolence—Irinotecan—lung cancer	0.000171	0.00112	CcSEcCtD
Rufinamide—Thrombocytopenia—Cisplatin—lung cancer	0.000171	0.00112	CcSEcCtD
Rufinamide—Headache—Topotecan—lung cancer	0.00017	0.00112	CcSEcCtD
Rufinamide—Rash—Erlotinib—lung cancer	0.00017	0.00111	CcSEcCtD
Rufinamide—Dermatitis—Erlotinib—lung cancer	0.00017	0.00111	CcSEcCtD
Rufinamide—Convulsion—Etoposide—lung cancer	0.00017	0.00111	CcSEcCtD
Rufinamide—Skin disorder—Cisplatin—lung cancer	0.000169	0.00111	CcSEcCtD
Rufinamide—Insomnia—Gemcitabine—lung cancer	0.000169	0.00111	CcSEcCtD
Rufinamide—Dyspepsia—Irinotecan—lung cancer	0.000169	0.00111	CcSEcCtD
Rufinamide—Immune system disorder—Docetaxel—lung cancer	0.000169	0.0011	CcSEcCtD
Rufinamide—Headache—Erlotinib—lung cancer	0.000169	0.0011	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—lung cancer	0.000169	0.0011	CcSEcCtD
Rufinamide—Mediastinal disorder—Docetaxel—lung cancer	0.000168	0.0011	CcSEcCtD
Rufinamide—Asthenia—Vinorelbine—lung cancer	0.000167	0.00109	CcSEcCtD
Rufinamide—Decreased appetite—Irinotecan—lung cancer	0.000167	0.00109	CcSEcCtD
Rufinamide—Nausea—Vinblastine—lung cancer	0.000166	0.00109	CcSEcCtD
Rufinamide—Somnolence—Gemcitabine—lung cancer	0.000166	0.00109	CcSEcCtD
Rufinamide—Convulsion—Paclitaxel—lung cancer	0.000166	0.00109	CcSEcCtD
Rufinamide—Anorexia—Cisplatin—lung cancer	0.000166	0.00109	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000166	0.00109	CcSEcCtD
Rufinamide—Fatigue—Irinotecan—lung cancer	0.000166	0.00108	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000165	0.00108	CcSEcCtD
Rufinamide—Pruritus—Vinorelbine—lung cancer	0.000165	0.00108	CcSEcCtD
Rufinamide—Constipation—Irinotecan—lung cancer	0.000164	0.00107	CcSEcCtD
Rufinamide—Mental disorder—Docetaxel—lung cancer	0.000164	0.00107	CcSEcCtD
Rufinamide—Anxiety—Paclitaxel—lung cancer	0.000163	0.00107	CcSEcCtD
Rufinamide—Malnutrition—Docetaxel—lung cancer	0.000163	0.00106	CcSEcCtD
Rufinamide—Decreased appetite—Gemcitabine—lung cancer	0.000163	0.00106	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000162	0.00106	CcSEcCtD
Rufinamide—Nausea—Topotecan—lung cancer	0.000162	0.00106	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000161	0.00106	CcSEcCtD
Rufinamide—Fatigue—Gemcitabine—lung cancer	0.000161	0.00106	CcSEcCtD
Rufinamide—Constipation—Gemcitabine—lung cancer	0.00016	0.00105	CcSEcCtD
Rufinamide—Nausea—Erlotinib—lung cancer	0.00016	0.00105	CcSEcCtD
Rufinamide—Diarrhoea—Vinorelbine—lung cancer	0.000159	0.00104	CcSEcCtD
Rufinamide—Infection—Etoposide—lung cancer	0.000159	0.00104	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—lung cancer	0.000158	0.00104	CcSEcCtD
Rufinamide—Back pain—Docetaxel—lung cancer	0.000157	0.00103	CcSEcCtD
Rufinamide—Neutropenia—Methotrexate—lung cancer	0.000157	0.00103	CcSEcCtD
Rufinamide—Dysuria—Methotrexate—lung cancer	0.000157	0.00103	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—lung cancer	0.000156	0.00102	CcSEcCtD
Rufinamide—Infection—Paclitaxel—lung cancer	0.000156	0.00102	CcSEcCtD
Rufinamide—Skin disorder—Etoposide—lung cancer	0.000155	0.00102	CcSEcCtD
Rufinamide—Dizziness—Vinorelbine—lung cancer	0.000154	0.00101	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—lung cancer	0.000154	0.00101	CcSEcCtD
Rufinamide—Nervous system disorder—Paclitaxel—lung cancer	0.000154	0.00101	CcSEcCtD
Rufinamide—Thrombocytopenia—Paclitaxel—lung cancer	0.000153	0.001	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—lung cancer	0.000152	0.000997	CcSEcCtD
Rufinamide—Anorexia—Etoposide—lung cancer	0.000152	0.000997	CcSEcCtD
Rufinamide—Skin disorder—Paclitaxel—lung cancer	0.000152	0.000996	CcSEcCtD
Rufinamide—Decreased appetite—Cisplatin—lung cancer	0.000152	0.000992	CcSEcCtD
Rufinamide—Pneumonia—Methotrexate—lung cancer	0.000151	0.000988	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—lung cancer	0.000151	0.000987	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Cisplatin—lung cancer	0.00015	0.000985	CcSEcCtD
Rufinamide—Anaemia—Docetaxel—lung cancer	0.00015	0.000984	CcSEcCtD
Rufinamide—Infestation—Methotrexate—lung cancer	0.00015	0.000982	CcSEcCtD
Rufinamide—Infestation NOS—Methotrexate—lung cancer	0.00015	0.000982	CcSEcCtD
Rufinamide—Anorexia—Paclitaxel—lung cancer	0.000149	0.000977	CcSEcCtD
Rufinamide—Vomiting—Vinorelbine—lung cancer	0.000148	0.000969	CcSEcCtD
Rufinamide—Rash—Vinorelbine—lung cancer	0.000147	0.000961	CcSEcCtD
Rufinamide—Dermatitis—Vinorelbine—lung cancer	0.000147	0.00096	CcSEcCtD
Rufinamide—Headache—Vinorelbine—lung cancer	0.000146	0.000955	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—lung cancer	0.000146	0.000954	CcSEcCtD
Rufinamide—Leukopenia—Docetaxel—lung cancer	0.000146	0.000953	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—lung cancer	0.000143	0.000936	CcSEcCtD
Rufinamide—Somnolence—Etoposide—lung cancer	0.000142	0.000929	CcSEcCtD
Rufinamide—Hepatobiliary disease—Methotrexate—lung cancer	0.000142	0.000929	CcSEcCtD
Rufinamide—Insomnia—Paclitaxel—lung cancer	0.000142	0.000927	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—lung cancer	0.000141	0.000926	CcSEcCtD
Rufinamide—Hypersensitivity—Irinotecan—lung cancer	0.000141	0.000926	CcSEcCtD
Rufinamide—Convulsion—Docetaxel—lung cancer	0.000141	0.000922	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—lung cancer	0.00014	0.000917	CcSEcCtD
Rufinamide—Somnolence—Paclitaxel—lung cancer	0.000139	0.000911	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—lung cancer	0.000139	0.000909	CcSEcCtD
Rufinamide—Nausea—Vinorelbine—lung cancer	0.000138	0.000905	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—lung cancer	0.000138	0.000903	CcSEcCtD
Rufinamide—Dyspepsia—Paclitaxel—lung cancer	0.000138	0.000902	CcSEcCtD
Rufinamide—Asthenia—Irinotecan—lung cancer	0.000138	0.000902	CcSEcCtD
Rufinamide—Fatigue—Etoposide—lung cancer	0.000138	0.000901	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000137	0.0009	CcSEcCtD
Rufinamide—Constipation—Etoposide—lung cancer	0.000137	0.000894	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—lung cancer	0.000136	0.000892	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—lung cancer	0.000136	0.000892	CcSEcCtD
Rufinamide—Decreased appetite—Paclitaxel—lung cancer	0.000136	0.000891	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000135	0.000885	CcSEcCtD
Rufinamide—Fatigue—Paclitaxel—lung cancer	0.000135	0.000884	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—lung cancer	0.000135	0.000881	CcSEcCtD
Rufinamide—Asthenia—Gemcitabine—lung cancer	0.000134	0.000878	CcSEcCtD
Rufinamide—Constipation—Paclitaxel—lung cancer	0.000134	0.000877	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—lung cancer	0.000133	0.00087	CcSEcCtD
Rufinamide—Pruritus—Gemcitabine—lung cancer	0.000132	0.000866	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—lung cancer	0.000132	0.000864	CcSEcCtD
Rufinamide—Infection—Docetaxel—lung cancer	0.000132	0.000863	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—lung cancer	0.000132	0.000863	CcSEcCtD
Rufinamide—Diarrhoea—Irinotecan—lung cancer	0.000131	0.00086	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—lung cancer	0.000131	0.000855	CcSEcCtD
Rufinamide—Nervous system disorder—Docetaxel—lung cancer	0.00013	0.000852	CcSEcCtD
Rufinamide—Thrombocytopenia—Docetaxel—lung cancer	0.00013	0.000851	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—lung cancer	0.00013	0.00085	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—lung cancer	0.00013	0.00085	CcSEcCtD
Rufinamide—Skin disorder—Docetaxel—lung cancer	0.000129	0.000844	CcSEcCtD
Rufinamide—Hypersensitivity—Cisplatin—lung cancer	0.000128	0.000841	CcSEcCtD
Rufinamide—Diarrhoea—Gemcitabine—lung cancer	0.000128	0.000838	CcSEcCtD
Rufinamide—Dizziness—Irinotecan—lung cancer	0.000127	0.000831	CcSEcCtD
Rufinamide—Anorexia—Docetaxel—lung cancer	0.000126	0.000828	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—lung cancer	0.000126	0.000824	CcSEcCtD
Rufinamide—Asthenia—Cisplatin—lung cancer	0.000125	0.000819	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—lung cancer	0.000125	0.000818	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—lung cancer	0.000124	0.000811	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—lung cancer	0.000123	0.000804	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—lung cancer	0.000122	0.000802	CcSEcCtD
Rufinamide—Vomiting—Irinotecan—lung cancer	0.000122	0.000799	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—lung cancer	0.000122	0.000798	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—lung cancer	0.000122	0.000796	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—lung cancer	0.000121	0.000794	CcSEcCtD
Rufinamide—Rash—Irinotecan—lung cancer	0.000121	0.000793	CcSEcCtD
Rufinamide—Dermatitis—Irinotecan—lung cancer	0.000121	0.000792	CcSEcCtD
Rufinamide—Headache—Irinotecan—lung cancer	0.00012	0.000787	CcSEcCtD
Rufinamide—Insomnia—Docetaxel—lung cancer	0.00012	0.000786	CcSEcCtD
Rufinamide—Diarrhoea—Cisplatin—lung cancer	0.000119	0.000781	CcSEcCtD
Rufinamide—Vomiting—Gemcitabine—lung cancer	0.000119	0.000778	CcSEcCtD
Rufinamide—Somnolence—Docetaxel—lung cancer	0.000118	0.000772	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—lung cancer	0.000118	0.000772	CcSEcCtD
Rufinamide—Rash—Gemcitabine—lung cancer	0.000118	0.000772	CcSEcCtD
Rufinamide—Dermatitis—Gemcitabine—lung cancer	0.000118	0.000771	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—lung cancer	0.000118	0.00077	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—lung cancer	0.000117	0.000767	CcSEcCtD
Rufinamide—Headache—Gemcitabine—lung cancer	0.000117	0.000767	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—lung cancer	0.000117	0.000765	CcSEcCtD
Rufinamide—Dyspepsia—Docetaxel—lung cancer	0.000117	0.000765	CcSEcCtD
Rufinamide—Decreased appetite—Docetaxel—lung cancer	0.000115	0.000755	CcSEcCtD
Rufinamide—Hypersensitivity—Paclitaxel—lung cancer	0.000115	0.000755	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—lung cancer	0.000115	0.000754	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000115	0.00075	CcSEcCtD
Rufinamide—Asthenia—Etoposide—lung cancer	0.000115	0.00075	CcSEcCtD
Rufinamide—Fatigue—Docetaxel—lung cancer	0.000114	0.000749	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—lung cancer	0.000114	0.000748	CcSEcCtD
Rufinamide—Nausea—Irinotecan—lung cancer	0.000114	0.000747	CcSEcCtD
Rufinamide—Constipation—Docetaxel—lung cancer	0.000113	0.000743	CcSEcCtD
Rufinamide—Back pain—Methotrexate—lung cancer	0.000113	0.000742	CcSEcCtD
Rufinamide—Pruritus—Etoposide—lung cancer	0.000113	0.00074	CcSEcCtD
Rufinamide—Asthenia—Paclitaxel—lung cancer	0.000112	0.000735	CcSEcCtD
Rufinamide—Nausea—Gemcitabine—lung cancer	0.000111	0.000727	CcSEcCtD
Rufinamide—Vomiting—Cisplatin—lung cancer	0.000111	0.000726	CcSEcCtD
Rufinamide—Pruritus—Paclitaxel—lung cancer	0.000111	0.000725	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—lung cancer	0.00011	0.000723	CcSEcCtD
Rufinamide—Rash—Cisplatin—lung cancer	0.00011	0.00072	CcSEcCtD
Rufinamide—Dermatitis—Cisplatin—lung cancer	0.00011	0.000719	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—lung cancer	0.000109	0.000715	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—lung cancer	0.000109	0.000713	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—lung cancer	0.000108	0.000709	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—lung cancer	0.000108	0.000708	CcSEcCtD
Rufinamide—Diarrhoea—Paclitaxel—lung cancer	0.000107	0.000701	CcSEcCtD
Rufinamide—Dizziness—Etoposide—lung cancer	0.000106	0.000691	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—lung cancer	0.000105	0.000689	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—lung cancer	0.000105	0.000689	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—lung cancer	0.000105	0.000688	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—lung cancer	0.000105	0.000687	CcSEcCtD
Rufinamide—Dizziness—Paclitaxel—lung cancer	0.000104	0.000678	CcSEcCtD
Rufinamide—Nausea—Cisplatin—lung cancer	0.000104	0.000678	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—lung cancer	0.000102	0.000669	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—lung cancer	0.000102	0.000665	CcSEcCtD
Rufinamide—Vomiting—Etoposide—lung cancer	0.000102	0.000665	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—lung cancer	0.000101	0.000664	CcSEcCtD
Rufinamide—Rash—Etoposide—lung cancer	0.000101	0.000659	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—lung cancer	0.000101	0.000659	CcSEcCtD
Rufinamide—Headache—Etoposide—lung cancer	0.0001	0.000655	CcSEcCtD
Rufinamide—Vomiting—Paclitaxel—lung cancer	9.95e-05	0.000652	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.91e-05	0.000649	CcSEcCtD
Rufinamide—Rash—Paclitaxel—lung cancer	9.87e-05	0.000646	CcSEcCtD
Rufinamide—Dermatitis—Paclitaxel—lung cancer	9.86e-05	0.000646	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—lung cancer	9.82e-05	0.000643	CcSEcCtD
Rufinamide—Headache—Paclitaxel—lung cancer	9.81e-05	0.000642	CcSEcCtD
Rufinamide—Hypersensitivity—Docetaxel—lung cancer	9.78e-05	0.00064	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—lung cancer	9.56e-05	0.000626	CcSEcCtD
Rufinamide—Asthenia—Docetaxel—lung cancer	9.52e-05	0.000623	CcSEcCtD
Rufinamide—Infection—Methotrexate—lung cancer	9.5e-05	0.000622	CcSEcCtD
Rufinamide—Nausea—Etoposide—lung cancer	9.48e-05	0.000621	CcSEcCtD
Rufinamide—Pruritus—Docetaxel—lung cancer	9.39e-05	0.000615	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—lung cancer	9.38e-05	0.000614	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—lung cancer	9.38e-05	0.000614	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—lung cancer	9.36e-05	0.000613	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—lung cancer	9.33e-05	0.000611	CcSEcCtD
Rufinamide—Nausea—Paclitaxel—lung cancer	9.3e-05	0.000609	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—lung cancer	9.29e-05	0.000608	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—lung cancer	9.12e-05	0.000597	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—lung cancer	9.12e-05	0.000597	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—lung cancer	9.08e-05	0.000595	CcSEcCtD
Rufinamide—Diarrhoea—Docetaxel—lung cancer	9.08e-05	0.000594	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—lung cancer	8.79e-05	0.000576	CcSEcCtD
Rufinamide—Dizziness—Docetaxel—lung cancer	8.78e-05	0.000575	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—lung cancer	8.65e-05	0.000566	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—lung cancer	8.61e-05	0.000564	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.58e-05	0.000562	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—lung cancer	8.5e-05	0.000557	CcSEcCtD
Rufinamide—Vomiting—Docetaxel—lung cancer	8.44e-05	0.000552	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—lung cancer	8.42e-05	0.000551	CcSEcCtD
Rufinamide—Rash—Docetaxel—lung cancer	8.37e-05	0.000548	CcSEcCtD
Rufinamide—Dermatitis—Docetaxel—lung cancer	8.36e-05	0.000547	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—lung cancer	8.31e-05	0.000544	CcSEcCtD
Rufinamide—Headache—Docetaxel—lung cancer	8.31e-05	0.000544	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—lung cancer	8.26e-05	0.000541	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—lung cancer	8.25e-05	0.00054	CcSEcCtD
Rufinamide—Infection—Doxorubicin—lung cancer	8.23e-05	0.000539	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—lung cancer	8.12e-05	0.000532	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—lung cancer	8.11e-05	0.000531	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—lung cancer	8.04e-05	0.000527	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—lung cancer	7.89e-05	0.000517	CcSEcCtD
Rufinamide—Nausea—Docetaxel—lung cancer	7.88e-05	0.000516	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—lung cancer	7.49e-05	0.00049	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—lung cancer	7.36e-05	0.000482	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—lung cancer	7.29e-05	0.000477	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—lung cancer	7.2e-05	0.000471	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—lung cancer	7.15e-05	0.000468	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—lung cancer	7.14e-05	0.000468	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—lung cancer	7.08e-05	0.000464	CcSEcCtD
Rufinamide—Hypersensitivity—Methotrexate—lung cancer	7.05e-05	0.000461	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—lung cancer	6.86e-05	0.000449	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—lung cancer	6.77e-05	0.000443	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—lung cancer	6.54e-05	0.000428	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—lung cancer	6.32e-05	0.000414	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—lung cancer	6.1e-05	0.0004	CcSEcCtD
Rufinamide—Vomiting—Methotrexate—lung cancer	6.08e-05	0.000398	CcSEcCtD
Rufinamide—Rash—Methotrexate—lung cancer	6.03e-05	0.000395	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—lung cancer	6.02e-05	0.000394	CcSEcCtD
Rufinamide—Headache—Methotrexate—lung cancer	5.99e-05	0.000392	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—lung cancer	5.94e-05	0.000389	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—lung cancer	5.86e-05	0.000384	CcSEcCtD
Rufinamide—Nausea—Methotrexate—lung cancer	5.68e-05	0.000372	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—lung cancer	5.67e-05	0.000371	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—lung cancer	5.48e-05	0.000359	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—lung cancer	5.27e-05	0.000345	CcSEcCtD
Rufinamide—Rash—Doxorubicin—lung cancer	5.22e-05	0.000342	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—lung cancer	5.22e-05	0.000342	CcSEcCtD
Rufinamide—Headache—Doxorubicin—lung cancer	5.19e-05	0.00034	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—lung cancer	4.92e-05	0.000322	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—CASP3—lung cancer	1.64e-05	0.000131	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—lung cancer	1.63e-05	0.00013	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTM1—lung cancer	1.63e-05	0.00013	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—lung cancer	1.63e-05	0.00013	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—lung cancer	1.63e-05	0.00013	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—lung cancer	1.62e-05	0.00013	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—lung cancer	1.62e-05	0.00013	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CKB—lung cancer	1.62e-05	0.00013	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EP300—lung cancer	1.61e-05	0.000129	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	1.61e-05	0.000129	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	1.61e-05	0.000128	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2A7—lung cancer	1.6e-05	0.000128	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—lung cancer	1.59e-05	0.000127	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—JUN—lung cancer	1.59e-05	0.000127	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—lung cancer	1.58e-05	0.000127	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—lung cancer	1.57e-05	0.000125	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—lung cancer	1.57e-05	0.000125	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SDC4—lung cancer	1.57e-05	0.000125	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SRC—lung cancer	1.57e-05	0.000125	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—lung cancer	1.56e-05	0.000125	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—lung cancer	1.56e-05	0.000125	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—lung cancer	1.56e-05	0.000125	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—lung cancer	1.55e-05	0.000124	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—lung cancer	1.55e-05	0.000123	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.54e-05	0.000123	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1A—lung cancer	1.54e-05	0.000123	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—lung cancer	1.54e-05	0.000123	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—lung cancer	1.53e-05	0.000122	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM2—lung cancer	1.52e-05	0.000122	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CNDP2—lung cancer	1.52e-05	0.000122	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.52e-05	0.000122	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—lung cancer	1.51e-05	0.000121	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—lung cancer	1.51e-05	0.000121	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—lung cancer	1.5e-05	0.00012	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—lung cancer	1.5e-05	0.00012	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—lung cancer	1.5e-05	0.00012	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—lung cancer	1.5e-05	0.00012	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTMR3—lung cancer	1.48e-05	0.000118	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—lung cancer	1.48e-05	0.000118	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EP300—lung cancer	1.47e-05	0.000117	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PGAM1—lung cancer	1.45e-05	0.000115	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK3—lung cancer	1.44e-05	0.000115	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	1.44e-05	0.000115	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—lung cancer	1.44e-05	0.000115	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—lung cancer	1.44e-05	0.000115	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RRM1—lung cancer	1.43e-05	0.000114	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTA3—lung cancer	1.43e-05	0.000114	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SRC—lung cancer	1.42e-05	0.000114	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	1.4e-05	0.000112	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ITGB1—lung cancer	1.39e-05	0.000111	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—lung cancer	1.39e-05	0.000111	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—lung cancer	1.39e-05	0.000111	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—lung cancer	1.39e-05	0.000111	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2A7—lung cancer	1.38e-05	0.00011	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—lung cancer	1.37e-05	0.00011	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—lung cancer	1.37e-05	0.00011	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—lung cancer	1.37e-05	0.00011	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.36e-05	0.000109	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AZIN2—lung cancer	1.36e-05	0.000109	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SDC4—lung cancer	1.35e-05	0.000108	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—B4GALT5—lung cancer	1.34e-05	0.000107	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK3—lung cancer	1.31e-05	0.000105	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTA4—lung cancer	1.31e-05	0.000104	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—lung cancer	1.3e-05	0.000104	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	1.29e-05	0.000103	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—lung cancer	1.28e-05	0.000102	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTA2—lung cancer	1.27e-05	0.000102	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—lung cancer	1.25e-05	9.98e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTA1—lung cancer	1.23e-05	9.82e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA3—lung cancer	1.23e-05	9.82e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RRM1—lung cancer	1.23e-05	9.82e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCC3—lung cancer	1.22e-05	9.71e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—lung cancer	1.18e-05	9.43e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1C1—lung cancer	1.18e-05	9.41e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—AVP—lung cancer	1.17e-05	9.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—B4GALT5—lung cancer	1.16e-05	9.23e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ATP5H—lung cancer	1.15e-05	9.23e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—POMC—lung cancer	1.15e-05	9.2e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—UGT1A1—lung cancer	1.14e-05	9.13e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	1.13e-05	9.07e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	1.13e-05	8.99e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA4—lung cancer	1.12e-05	8.98e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—lung cancer	1.1e-05	8.82e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNG11—lung cancer	1.1e-05	8.81e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.1e-05	8.78e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	1.1e-05	8.76e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA2—lung cancer	1.1e-05	8.75e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—lung cancer	1.08e-05	8.66e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MMP1—lung cancer	1.08e-05	8.65e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA1—lung cancer	1.06e-05	8.44e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—lung cancer	1.06e-05	8.44e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALDOA—lung cancer	1.05e-05	8.38e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—lung cancer	1.05e-05	8.38e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCC3—lung cancer	1.04e-05	8.35e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.04e-05	8.29e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—APOA1—lung cancer	1.04e-05	8.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLBD1—lung cancer	1.03e-05	8.22e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA3—lung cancer	1.02e-05	8.14e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1C1—lung cancer	1.01e-05	8.08e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—lung cancer	1e-05	8.01e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADCY1—lung cancer	9.91e-06	7.92e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCG2—lung cancer	9.91e-06	7.92e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—UGT1A1—lung cancer	9.82e-06	7.85e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—lung cancer	9.75e-06	7.79e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO2—lung cancer	9.72e-06	7.76e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HPGDS—lung cancer	9.72e-06	7.76e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPP2R1B—lung cancer	9.66e-06	7.72e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—lung cancer	9.6e-06	7.67e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNG11—lung cancer	9.47e-06	7.57e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—lung cancer	9.45e-06	7.55e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—lung cancer	9.43e-06	7.53e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.42e-06	7.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD17B10—lung cancer	9.41e-06	7.52e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EGF—lung cancer	9.34e-06	7.46e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GCLC—lung cancer	9.32e-06	7.44e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2A6—lung cancer	9.32e-06	7.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALDOA—lung cancer	9.02e-06	7.21e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	8.96e-06	7.16e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—lung cancer	8.85e-06	7.07e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO1—lung cancer	8.83e-06	7.06e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CREBBP—lung cancer	8.76e-06	7e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA3—lung cancer	8.75e-06	6.99e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CKB—lung cancer	8.75e-06	6.99e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.6e-06	6.87e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	8.56e-06	6.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADCY1—lung cancer	8.52e-06	6.8e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG2—lung cancer	8.52e-06	6.8e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HPGDS—lung cancer	8.35e-06	6.67e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO2—lung cancer	8.35e-06	6.67e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—lung cancer	8.31e-06	6.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPP2R1B—lung cancer	8.3e-06	6.63e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM2—lung cancer	8.23e-06	6.57e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CNDP2—lung cancer	8.23e-06	6.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.19e-06	6.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—lung cancer	8.1e-06	6.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2A6—lung cancer	8.01e-06	6.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GCLC—lung cancer	8.01e-06	6.4e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTMR3—lung cancer	8e-06	6.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.98e-06	6.37e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NQO1—lung cancer	7.83e-06	6.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PGAM1—lung cancer	7.8e-06	6.23e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO1—lung cancer	7.59e-06	6.06e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	7.58e-06	6.06e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.56e-06	6.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2A7—lung cancer	7.44e-06	5.95e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RAF1—lung cancer	7.42e-06	5.93e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SDC4—lung cancer	7.28e-06	5.82e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—lung cancer	7.24e-06	5.79e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—STK11—lung cancer	7.06e-06	5.64e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	7e-06	5.59e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2E1—lung cancer	6.81e-06	5.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NQO1—lung cancer	6.73e-06	5.38e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—lung cancer	6.65e-06	5.31e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RRM1—lung cancer	6.63e-06	5.3e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA3—lung cancer	6.63e-06	5.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.59e-06	5.27e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—lung cancer	6.53e-06	5.22e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.53e-06	5.22e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	6.42e-06	5.13e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAT—lung cancer	6.36e-06	5.08e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—B4GALT5—lung cancer	6.24e-06	4.98e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—lung cancer	6.18e-06	4.94e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMS—lung cancer	6.07e-06	4.85e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STK11—lung cancer	6.07e-06	4.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA4—lung cancer	6.07e-06	4.85e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—lung cancer	6e-06	4.8e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EP300—lung cancer	5.97e-06	4.77e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA2—lung cancer	5.91e-06	4.72e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—lung cancer	5.8e-06	4.64e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA1—lung cancer	5.7e-06	4.56e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.7e-06	4.55e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1A1—lung cancer	5.69e-06	4.55e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—lung cancer	5.65e-06	4.52e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ERCC2—lung cancer	5.64e-06	4.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCC3—lung cancer	5.64e-06	4.51e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—lung cancer	5.61e-06	4.49e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—lung cancer	5.58e-06	4.46e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAT—lung cancer	5.46e-06	4.37e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1C1—lung cancer	5.46e-06	4.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.43e-06	4.34e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK3—lung cancer	5.35e-06	4.27e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—lung cancer	5.32e-06	4.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UGT1A1—lung cancer	5.3e-06	4.24e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMS—lung cancer	5.22e-06	4.17e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—lung cancer	5.16e-06	4.12e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNG11—lung cancer	5.11e-06	4.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1A1—lung cancer	4.89e-06	3.91e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOA1—lung cancer	4.88e-06	3.9e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALDOA—lung cancer	4.87e-06	3.89e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ERCC2—lung cancer	4.85e-06	3.88e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—lung cancer	4.8e-06	3.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA3—lung cancer	4.73e-06	3.78e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADCY1—lung cancer	4.6e-06	3.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG2—lung cancer	4.6e-06	3.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPGDS—lung cancer	4.51e-06	3.6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO2—lung cancer	4.51e-06	3.6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.48e-06	3.58e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—lung cancer	4.46e-06	3.56e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—lung cancer	4.41e-06	3.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—lung cancer	4.37e-06	3.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2A6—lung cancer	4.32e-06	3.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCLC—lung cancer	4.32e-06	3.45e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—lung cancer	4.27e-06	3.41e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POMC—lung cancer	4.24e-06	3.39e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOA1—lung cancer	4.2e-06	3.35e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CREBBP—lung cancer	4.13e-06	3.3e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO1—lung cancer	4.1e-06	3.27e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—lung cancer	4.08e-06	3.26e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.02e-06	3.21e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—lung cancer	3.92e-06	3.13e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—lung cancer	3.87e-06	3.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—lung cancer	3.83e-06	3.06e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2E1—lung cancer	3.68e-06	2.94e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POMC—lung cancer	3.65e-06	2.91e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NQO1—lung cancer	3.63e-06	2.9e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—lung cancer	3.61e-06	2.88e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CREBBP—lung cancer	3.55e-06	2.84e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—lung cancer	3.42e-06	2.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—lung cancer	3.38e-06	2.7e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—lung cancer	3.37e-06	2.69e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STK11—lung cancer	3.28e-06	2.62e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—lung cancer	3.03e-06	2.42e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—lung cancer	2.95e-06	2.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAT—lung cancer	2.95e-06	2.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—lung cancer	2.94e-06	2.35e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—lung cancer	2.91e-06	2.32e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—lung cancer	2.87e-06	2.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMS—lung cancer	2.82e-06	2.25e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—EP300—lung cancer	2.82e-06	2.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—lung cancer	2.79e-06	2.23e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1A1—lung cancer	2.64e-06	2.11e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ERCC2—lung cancer	2.62e-06	2.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—lung cancer	2.54e-06	2.03e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EP300—lung cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOA1—lung cancer	2.27e-06	1.81e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—lung cancer	2.08e-06	1.66e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—lung cancer	2.07e-06	1.65e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POMC—lung cancer	1.97e-06	1.57e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CREBBP—lung cancer	1.92e-06	1.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—lung cancer	1.82e-06	1.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—lung cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—lung cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—lung cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—lung cancer	1.58e-06	1.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—lung cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—lung cancer	1.46e-06	1.17e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—lung cancer	1.37e-06	1.09e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EP300—lung cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—lung cancer	9.66e-07	7.72e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—lung cancer	7.89e-07	6.31e-06	CbGpPWpGaD
